- Could a Single Shot at Birth Shield Kids From HIV for Years?
Tulane researchers said that’s roughly the equivalent of a treatment that could ward off HIV in humans deep into adolescence If the gene therapy was delivered even a bit later — 8 to 12 weeks after birth — the young monkey's more developed immune system swung into action to fight it, eroding its effectiveness
- Matulane Uses, Side Effects Warnings - Drugs. com
Matulane: side effects, dosage, interactions, FAQs, reviews Used for: anaplastic astrocytoma, anaplastic oligodendroglioma, glioblastoma multiforme, hodgkin's lymphoma
- Monthly Obesity Shot, MariTide, Shows Big Weight Loss in Trial
Weight loss among those with type 2 diabetes averaged 13 7% Dr Shauna Levy, medical director of the Tulane Bariatric Center in New Orleans, hailed the growing number of potential options for patients "It’s long been thought that obesity is an easy disease to treat, but in reality, it’s actually very difficult," she told NBC News
- Healthy Habits Slash Genetic Dementia Risk in Adults with Type 2 . . .
Study author Yilin Yoshida of Tulane University School of Medicine in New Orleans highlighted the overlap between diabetes and heart health “There are multiple factors associated with type 2 diabetes that contribute to an increased risk of cognitive decline and dementia
- FDA Approves Polypill Widaplik for Hypertension - Drugs. com
"I am very excited and pleased to have Widaplik approved for the treatment of hypertension in the U S Single-pill combination antihypertensive therapy has great potential to improve hypertension control in the U S and worldwide," Paul Whelton, M D , of Tulane University in New Orleans and past president of the World Hypertension League, said
- American Academy of Pediatrics, Sept. 26-30 - Drugs. com
The annual meeting of the American Academy of Pediatrics was held this year from Sept 26 to 30 in Denver and attracted participants from around the world, incl
- FDA Approves Widaplik (telmisartan, amlodipine and indapamide) for the . . .
FDA approves Widaplik (telmisartan, amlodipine, indapamide) for adults with hypertension, including as initial therapy, to help lower blood pressure
|